With the most recent release of data from the National Oncologic PET Registry, researchers may have reached the moment of critical mass by confirming the effectiveness of positron emission tomography in the monitoring of tumor activity across a wide range of cancers. In the article, researchers reported results by cancer type for the first two years of data collected from nearly 41,000 PET studies conducted at more than 1,300 cancer centers nationwide.